54
Growth Score
pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
478303
Artificial Cell Technologies is a Biotechnology technology.
- Donald Masters: CEO
About the Company
Artificial Cell Technologies (ACT) is redefining the manufacturing of globally available vaccines. This New Haven based firm is actively developing the first patented technology for rapid, synthetic vaccine production. Their unique approach allows ACT to produce multi-valent vaccines exponentially faster, and capable of personalization. This also
allows the vaccines to be produced on-demand.
